Key result
Medicated primary aldosteronism linked to ~8% higher cardiac output versus medicated essential hypertension.
Why the study?
Primary aldosteronism is usually diagnosed while patients are taking antihypertensive medications, prompting comparison of haemodynamics across hypertensive and control groups.
Cross-Sectional (n=520)
Medicated primary aldosteronism is characterized by higher extracellular water volume, cardiac output, and arterial stiffness compared to medicated essential hypertension.
Medicated primary aldosteronism was associated with higher extracellular water and cardiac output; hypothesis-generating versus essential hypertension, prospective studies needed before clinical implications.
BACKGROUND: The diagnostics of primary aldosteronism (PA) are usually carried out in patients taking antihypertensive medications. We compared haemodynamics between medicated PA, medicated essential hypertension (EH), never-medicated EH and normotensive controls (n = 130 in all groups). METHODS: ). Haemodynamics were recorded using whole-body impedance cardiography and radial pulse wave analysis, and the results were adjusted as appropriate. Radial blood pressure recordings were calibrated by brachial blood pressure measurements from the contralateral arm. RESULTS: Radial and aortic systolic and diastolic blood pressure was similar in PA and never-medicated EH, and higher than in medicated EH and normotensive controls (P ≤ 0.001 for all comparisons). Extracellular water balance was ~ 4% higher in PA than in all other groups (P < 0.05 for all), whilst cardiac output was ~ 8% higher in PA than in medicated EH (P = 0.012). Systemic vascular resistance and augmentation index were similarly increased in PA and both EH groups when compared with controls. Pulse wave velocity was higher in PA and never-medicated EH than in medicated EH and normotensive controls (P ≤ 0.033 for all comparisons). CONCLUSIONS: Medicated PA patients presented with corresponding systemic vascular resistance and wave reflection, but higher extracellular water volume, cardiac output and arterial stiffness than medicated EH patients. Whether the systematic evaluation of these features would benefit the clinical diagnostics of PA remains to be studied in future.
No takes yet. Share an insight, caveat, or question.
Choudhary et al. (2020) conducted a cross-sectional in Primary aldosteronism and essential hypertension (n=520). Medicated primary aldosteronism vs. Medicated essential hypertension, never-medicated essential hypertension, and normotensive controls was evaluated on Haemodynamics (extracellular water balance, cardiac output, arterial stiffness). Medicated primary aldosteronism patients had ~4% higher extracellular water balance (P<0.05) and ~8% higher cardiac output (P=0.012) compared to medicated essential hypertension patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: